Diagnosis and management of neuropathic pain among cancer patient in UKMMC

Y. C. Choy, Ag Muhammad Hazim, Bs Yap, Ch Yap, R. Hannah, Ch Chan, N. Nurul Hakimi

    Research output: Contribution to journalArticle

    Abstract

    Background: Pain is a common problem affecting patients suffering from cancer. Majority of the pain is nociceptive in nature, however, a small percentage of these patients have neuropathic pain which is frequently undiagnosed and not properly managed. Patient and method: This was an observational, cross sectional study to evaluate the prevalence of neuropathic pain among cancer patients and its management in Universiti Kebangsaan Malaysia Medical Centre (UKMMC). The nature of neuropathic pain was studied, a pain assessment tool, (ID Pain) was used to identify the presence of neuropathic pain, drug therapy was investigated and patient satisfaction was also assessed. Results: One hundred cancer patients with significant complain of pain participated in a 4-weeks study. The mean age was 53.1 years, 40 males and 60 females. In the study sample, 43 patients (43%) were identified to have neuropathic pain. Neuropathic pain caused significant impairment of sleep and daily activity (χ2 test, p=0.003 and p=0.013) respectively. Out of these 43 patients, 31 [72.1%) were managed according to WHO analgesic ladder guidelines, using analgesics only without adjuvant, whereas, 7 [16.3%) received analgesics plus adjuvant therapy which is an essential component in the management of neuropathic pain. Patients treated according to WHO guideline resulted in significant improvement in satisfaction (Fisher Exact test, p=0.03). There was also significant improvement of pain score (visual analogue score) among these patients after receiving treatment (Paired t-test, p=0.00). Conclusions: the prevalence of neuropathic pain in cancer patients was comparable to that reported in the literature, symptom burden was significant and treatment with adjuvant analgesics were lacking. However patient satisfaction was acceptable, but could be improved if awareness among health care providers in recognising neuropathic pain and the importance of applying proper treatment regimens were emphasised.

    Original languageEnglish
    Pages (from-to)10-16
    Number of pages7
    JournalNew Iraqi Journal of Medicine
    Volume7
    Issue number3
    Publication statusPublished - Dec 2011

    Fingerprint

    Malaysia
    Neuralgia
    Neoplasms
    Analgesics
    Pain
    Patient Satisfaction
    Guidelines
    Nociceptive Pain
    Pain Measurement
    Therapeutics
    Health Personnel
    Sleep
    Cross-Sectional Studies
    Drug Therapy

    Keywords

    • Adjuvant analgesic
    • Cancer
    • Neuropathic pain
    • Opioids
    • WHO analgesic ladder

    ASJC Scopus subject areas

    • Medicine(all)

    Cite this

    Choy, Y. C., Hazim, A. M., Yap, B., Yap, C., Hannah, R., Chan, C., & Hakimi, N. N. (2011). Diagnosis and management of neuropathic pain among cancer patient in UKMMC. New Iraqi Journal of Medicine, 7(3), 10-16.

    Diagnosis and management of neuropathic pain among cancer patient in UKMMC. / Choy, Y. C.; Hazim, Ag Muhammad; Yap, Bs; Yap, Ch; Hannah, R.; Chan, Ch; Hakimi, N. Nurul.

    In: New Iraqi Journal of Medicine, Vol. 7, No. 3, 12.2011, p. 10-16.

    Research output: Contribution to journalArticle

    Choy, YC, Hazim, AM, Yap, B, Yap, C, Hannah, R, Chan, C & Hakimi, NN 2011, 'Diagnosis and management of neuropathic pain among cancer patient in UKMMC', New Iraqi Journal of Medicine, vol. 7, no. 3, pp. 10-16.
    Choy YC, Hazim AM, Yap B, Yap C, Hannah R, Chan C et al. Diagnosis and management of neuropathic pain among cancer patient in UKMMC. New Iraqi Journal of Medicine. 2011 Dec;7(3):10-16.
    Choy, Y. C. ; Hazim, Ag Muhammad ; Yap, Bs ; Yap, Ch ; Hannah, R. ; Chan, Ch ; Hakimi, N. Nurul. / Diagnosis and management of neuropathic pain among cancer patient in UKMMC. In: New Iraqi Journal of Medicine. 2011 ; Vol. 7, No. 3. pp. 10-16.
    @article{ff785e40787446b792732f6f1e7745c6,
    title = "Diagnosis and management of neuropathic pain among cancer patient in UKMMC",
    abstract = "Background: Pain is a common problem affecting patients suffering from cancer. Majority of the pain is nociceptive in nature, however, a small percentage of these patients have neuropathic pain which is frequently undiagnosed and not properly managed. Patient and method: This was an observational, cross sectional study to evaluate the prevalence of neuropathic pain among cancer patients and its management in Universiti Kebangsaan Malaysia Medical Centre (UKMMC). The nature of neuropathic pain was studied, a pain assessment tool, (ID Pain) was used to identify the presence of neuropathic pain, drug therapy was investigated and patient satisfaction was also assessed. Results: One hundred cancer patients with significant complain of pain participated in a 4-weeks study. The mean age was 53.1 years, 40 males and 60 females. In the study sample, 43 patients (43{\%}) were identified to have neuropathic pain. Neuropathic pain caused significant impairment of sleep and daily activity (χ2 test, p=0.003 and p=0.013) respectively. Out of these 43 patients, 31 [72.1{\%}) were managed according to WHO analgesic ladder guidelines, using analgesics only without adjuvant, whereas, 7 [16.3{\%}) received analgesics plus adjuvant therapy which is an essential component in the management of neuropathic pain. Patients treated according to WHO guideline resulted in significant improvement in satisfaction (Fisher Exact test, p=0.03). There was also significant improvement of pain score (visual analogue score) among these patients after receiving treatment (Paired t-test, p=0.00). Conclusions: the prevalence of neuropathic pain in cancer patients was comparable to that reported in the literature, symptom burden was significant and treatment with adjuvant analgesics were lacking. However patient satisfaction was acceptable, but could be improved if awareness among health care providers in recognising neuropathic pain and the importance of applying proper treatment regimens were emphasised.",
    keywords = "Adjuvant analgesic, Cancer, Neuropathic pain, Opioids, WHO analgesic ladder",
    author = "Choy, {Y. C.} and Hazim, {Ag Muhammad} and Bs Yap and Ch Yap and R. Hannah and Ch Chan and Hakimi, {N. Nurul}",
    year = "2011",
    month = "12",
    language = "English",
    volume = "7",
    pages = "10--16",
    journal = "New Iraqi Journal of Medicine",
    issn = "1817-5562",
    publisher = "Iraqi Ministry of Health",
    number = "3",

    }

    TY - JOUR

    T1 - Diagnosis and management of neuropathic pain among cancer patient in UKMMC

    AU - Choy, Y. C.

    AU - Hazim, Ag Muhammad

    AU - Yap, Bs

    AU - Yap, Ch

    AU - Hannah, R.

    AU - Chan, Ch

    AU - Hakimi, N. Nurul

    PY - 2011/12

    Y1 - 2011/12

    N2 - Background: Pain is a common problem affecting patients suffering from cancer. Majority of the pain is nociceptive in nature, however, a small percentage of these patients have neuropathic pain which is frequently undiagnosed and not properly managed. Patient and method: This was an observational, cross sectional study to evaluate the prevalence of neuropathic pain among cancer patients and its management in Universiti Kebangsaan Malaysia Medical Centre (UKMMC). The nature of neuropathic pain was studied, a pain assessment tool, (ID Pain) was used to identify the presence of neuropathic pain, drug therapy was investigated and patient satisfaction was also assessed. Results: One hundred cancer patients with significant complain of pain participated in a 4-weeks study. The mean age was 53.1 years, 40 males and 60 females. In the study sample, 43 patients (43%) were identified to have neuropathic pain. Neuropathic pain caused significant impairment of sleep and daily activity (χ2 test, p=0.003 and p=0.013) respectively. Out of these 43 patients, 31 [72.1%) were managed according to WHO analgesic ladder guidelines, using analgesics only without adjuvant, whereas, 7 [16.3%) received analgesics plus adjuvant therapy which is an essential component in the management of neuropathic pain. Patients treated according to WHO guideline resulted in significant improvement in satisfaction (Fisher Exact test, p=0.03). There was also significant improvement of pain score (visual analogue score) among these patients after receiving treatment (Paired t-test, p=0.00). Conclusions: the prevalence of neuropathic pain in cancer patients was comparable to that reported in the literature, symptom burden was significant and treatment with adjuvant analgesics were lacking. However patient satisfaction was acceptable, but could be improved if awareness among health care providers in recognising neuropathic pain and the importance of applying proper treatment regimens were emphasised.

    AB - Background: Pain is a common problem affecting patients suffering from cancer. Majority of the pain is nociceptive in nature, however, a small percentage of these patients have neuropathic pain which is frequently undiagnosed and not properly managed. Patient and method: This was an observational, cross sectional study to evaluate the prevalence of neuropathic pain among cancer patients and its management in Universiti Kebangsaan Malaysia Medical Centre (UKMMC). The nature of neuropathic pain was studied, a pain assessment tool, (ID Pain) was used to identify the presence of neuropathic pain, drug therapy was investigated and patient satisfaction was also assessed. Results: One hundred cancer patients with significant complain of pain participated in a 4-weeks study. The mean age was 53.1 years, 40 males and 60 females. In the study sample, 43 patients (43%) were identified to have neuropathic pain. Neuropathic pain caused significant impairment of sleep and daily activity (χ2 test, p=0.003 and p=0.013) respectively. Out of these 43 patients, 31 [72.1%) were managed according to WHO analgesic ladder guidelines, using analgesics only without adjuvant, whereas, 7 [16.3%) received analgesics plus adjuvant therapy which is an essential component in the management of neuropathic pain. Patients treated according to WHO guideline resulted in significant improvement in satisfaction (Fisher Exact test, p=0.03). There was also significant improvement of pain score (visual analogue score) among these patients after receiving treatment (Paired t-test, p=0.00). Conclusions: the prevalence of neuropathic pain in cancer patients was comparable to that reported in the literature, symptom burden was significant and treatment with adjuvant analgesics were lacking. However patient satisfaction was acceptable, but could be improved if awareness among health care providers in recognising neuropathic pain and the importance of applying proper treatment regimens were emphasised.

    KW - Adjuvant analgesic

    KW - Cancer

    KW - Neuropathic pain

    KW - Opioids

    KW - WHO analgesic ladder

    UR - http://www.scopus.com/inward/record.url?scp=83455235883&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=83455235883&partnerID=8YFLogxK

    M3 - Article

    VL - 7

    SP - 10

    EP - 16

    JO - New Iraqi Journal of Medicine

    JF - New Iraqi Journal of Medicine

    SN - 1817-5562

    IS - 3

    ER -